An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age45-70

SponsorAnhui Provincial Hospital

About this trial

To evaluate the long-term safety of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

Subjects who have previously participated in RGL-193-related studies and have received RGL-193 treatment；

Those who voluntarily participate in this trial and sign a written informed consent form -

None

6 Participants

are divided into 1 treatment group

This trial has no locations

Anhui Provincial Hospital

Lead sponsor